1
Clinical Trials associated with INV-101(Innovo Therapeutics)A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose, and Food-Effect Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of INV-101 Administered Orally to Healthy Adult Subjects
This is a 2-part study. Parts 1 and 2 will be a randomized, double-blind, placebo-controlled investigations of SAD (Part 1) and MAD (Part 2) of orally administered INV-101 in healthy adult subjects. Food effect will also be assessed in one cohort in Part 1.
100 Clinical Results associated with INV-101(Innovo Therapeutics)
100 Translational Medicine associated with INV-101(Innovo Therapeutics)
100 Patents (Medical) associated with INV-101(Innovo Therapeutics)
100 Deals associated with INV-101(Innovo Therapeutics)